These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15191000)

  • 21. [Changeover to risperidone after treatment with conventional low potency neuroleptics in dementia patients. An observation study during usage].
    Stoppe G; Schreiner A; Schmitt AB
    Dtsch Med Wochenschr; 2006 Mar; 131(9):423-9. PubMed ID: 16493564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia.
    Martin H; Slyk MP; Deymann S; Cornacchione MJ
    J Am Med Dir Assoc; 2003; 4(4):183-8. PubMed ID: 12837138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recognition and treatment of behavioral and psychological symptoms of dementias: lessons from the CATIE-AD study].
    Kálmán J; Kálmán S; Pákáski M
    Neuropsychopharmacol Hung; 2008 Oct; 10(4):233-49. PubMed ID: 19213202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of atypical antipsychotics in elderly patients with dementia.
    Tariot PN; Profenno LA; Ismail MS
    J Clin Psychiatry; 2004; 65 Suppl 11():11-5. PubMed ID: 15264966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical antipsychotics for nursing home patients: a retrospective chart review.
    Frenchman IB
    Drugs Aging; 2005; 22(3):257-64. PubMed ID: 15813657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of antipsychotics among people treated with medications for dementia in residential aged care facilities.
    Shin HY; Gadzhanova S; Roughead EE; Ward MB; Pont LG
    Int Psychogeriatr; 2016 Jun; 28(6):977-82. PubMed ID: 26775538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality in elderly dementia patients treated with risperidone.
    Haupt M; Cruz-Jentoft A; Jeste D
    J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficasy and safety of the use of risperidone (rispoluxe) in demented patients with psychotic and behavioural disorders].
    Bocharov AV; Kondakova VE; Tuleninov ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6):25-31. PubMed ID: 22983233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone.
    Jeste DV; Okamoto A; Napolitano J; Kane JM; Martinez RA
    Am J Psychiatry; 2000 Jul; 157(7):1150-5. PubMed ID: 10873925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].
    Pinheiro D
    Encephale; 2008 Sep; 34(4):409-15. PubMed ID: 18922244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS).
    Ruths S; Straand J; Nygaard HA; Aarsland D
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):889-95. PubMed ID: 18306150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
    Turgay A; Binder C; Snyder R; Fisman S
    Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Atypical antipsychotics in elderly patients with dementia].
    Selbaek G; Engedal K
    Tidsskr Nor Laegeforen; 2008 May; 128(9):1060-1. PubMed ID: 18451888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.
    Lee PE; Gill SS; Freedman M; Bronskill SE; Hillmer MP; Rochon PA
    BMJ; 2004 Jul; 329(7457):75. PubMed ID: 15194601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update.
    DeVane CL; Mintzer J
    Psychopharmacol Bull; 2003; 37(4):116-32. PubMed ID: 15131522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings.
    Bullock R
    Curr Med Res Opin; 2005 Jan; 21(1):1-10. PubMed ID: 15881470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities.
    Ballard CG; Margallo-Lana ML
    J Clin Psychiatry; 2004; 65 Suppl 11():23-8. PubMed ID: 15264968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.